Fischer Medical Ventures Ltd

Fischer Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fischer Medical Ventures Ltd

₹ 840 0.24%
21 May 2:35 p.m.
fischermv.com BSE: 524743
About

Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]

Key Points

Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals

Website BSE
  • Market Cap ₹ 5,359 Cr.
  • Current Price ₹ 840
  • High / Low ₹ 919 / 527
  • Stock P/E 2,393
  • Book Value ₹ 15.2
  • Dividend Yield 0.00 %
  • ROCE 5.25 %
  • ROE 4.55 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 55.2 times its book value
  • Promoter holding has decreased over last quarter: -13.1%
  • Earnings include an other income of Rs.1.42 Cr.
  • Company has high debtors of 398 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
0.00 20.79 10.12 39.66 11.75
0.00 18.28 10.29 39.16 11.25
Operating Profit 0.00 2.51 -0.17 0.50 0.50
OPM % 12.07% -1.68% 1.26% 4.26%
0.00 0.47 0.65 0.05 0.25
Interest 0.00 0.05 0.13 0.05 0.07
Depreciation 0.00 0.18 0.28 0.29 0.56
Profit before tax 0.00 2.75 0.07 0.21 0.12
Tax % 6.18% 271.43% -38.10% 350.00%
0.00 2.59 -0.12 0.29 -0.29
EPS in Rs 0.00 0.48 -0.02 0.05 -0.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 TTM
0.18 20.98 82.32
0.16 19.12 78.98
Operating Profit 0.02 1.86 3.34
OPM % 11.11% 8.87% 4.06%
0.00 0.50 1.42
Interest 0.02 0.07 0.30
Depreciation 0.00 0.18 1.31
Profit before tax 0.00 2.11 3.15
Tax % 12.80%
-0.04 1.84 2.47
EPS in Rs -2.33 0.34 0.46
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 11556%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 4700%
Stock Price CAGR
10 Years: 72%
5 Years: 80%
3 Years: 155%
1 Year: 54%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.17 53.50 53.50
Reserves -0.44 27.61 27.95
0.57 1.68 1.47
0.05 3.53 57.80
Total Liabilities 0.35 86.32 140.72
0.00 14.71 14.87
CWIP 0.00 0.00 2.89
Investments 0.00 1.21 11.70
0.35 70.40 111.26
Total Assets 0.35 86.32 140.72

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
-7.59
-28.61
37.11
Net Cash Flow 0.91

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 344.72 397.88
Inventory Days
Days Payable
Cash Conversion Cycle 344.72 397.88
Working Capital Days 324.44 505.40
ROCE % 5.25%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.38%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42%
100.00% 100.00% 100.00% 99.99% 100.00% 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.41%
No. of Shareholders 9,1219,0649,0609,1009,1049,0388,9769,2859,5029,68810,18010,182

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Dec 2024
    Transcript
    Notes
    PPT